All News

Feds claim results of study comparing car crash deaths and children on ADHD drugs were not paramount to pulling kids off of ADHD treatments.

12 June 2009

The Word Health Organization just bumped the H1N1 influenza to pandemic alert phase 6 (the highest alert level), making it the first worldwide pandemic in 41 years.

What do you do when you are introducing a new drug in an already crowded category? Wyeth queried depression sufferers to find out what they want to see in a drug ad before launching its new DTC campaign for Pristiq.

GlaxoSmithKline is expanding its influenza vaccine efforts through a joint R&D alliance with Shenzhen Neptunus. The goal: to tap the world’s biggest market and attempt to deliver flu shots to more than a billion people.

The pharmaceutical industry distributes more than $22 billion worth of medication samples in the US alone. It's time to revisit the issue of waste inherent in this marketing strategy.

One of the fastest growing segments in the industry, specialty pharmaceuticals are proving tough to track for most companies-creating critical gaps in the supply chain view that can distort strategic planning and impact competitive advantage.

2008?2010

4 June 2009

GlaxoSmithKline has entered into a collaboration deal with Concert to create drugs using deuterium-“heavy hydrogen”-that can be gathered from seawater and used to alter the way molecules perform in the body.

The feds green lit a task force charged with easing the flow of communication between FDA, pharma companies, and the general public. While the team is being billed as a task force for transparency, it?s still unclear what is being revealed.

What can change is what advertisers depict in many of the DTC ads for serious health-threatening conditions: the happy patient.

Virtually all pharmaceutical manufacturers have robust policies to place needed medicines in the hands of those who cannot afford to pay for them.

To help make the most out of a client's marketing spend, the preferred method is to utilize hard data, such as new patient starts, or prescription movement.

Agency Confidential interrogated 21 executives at top healthcare agencies to find out the skinny on what is really happening with pharma marketing and advertising at this dire time for the industry. Here is the report.

At the end of the day you have tribes, some frequently not on the same "brand" page.

It used to be that sacrificing one's own health was not an option. So now new responsibility has emerged for marketers.

Research shows that budget cuts on advertising and marketing during times of recession have a long term negative impact.

Pharma marketers must focus their efforts and resources on changing the behavior of professionals and concumsers.

It may not be sexy but now, more than ever, marketers need to look at their analytics.

This latest action from the FDA has resulted in confusion, a need for counsel, and conjecture at what might be next.

When economizing on agency spend, a key question needs to be answered: "Are you getting great value for your promotion?"

Pharma vet Hans Bishop readily admits to being ruthless in his career.

Jennifer Spear Smith may be soft-spoken and petite, but she is loud, clear, and stands tall for one part of industry that she is clearly passionate about: continuing medical education (CME).

I started off as a pathologist at Boehringer-Ingelheim in Germany.

I got my first taste of this industry as an intern at Schering-Plough's Managed Care group.

My first introductions to medically relevant biology and chemistry began when I worked with Harvard professor Greg Verdine to figure out how enzymes recognized and repaired damaged DNA.

I started my career as a medical liaison. It was a wonderful opportunity to shape how companies and physicians further scientific understanding of difficult medical problems, focus on key research questions, and address unmet patient needs.